NCT05800535View on ClinicalTrials.gov

JUMP Prevalence of Sarcopenia and Chemobrain in Post-cancer Patients

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
CancerSarcopenia
Interventions
DRUG

Study of the adverse effects of long-term oncological treatments

Cognitive and muscular evaluation of patients who have received oncological treatments, away from the latest treatments to assess their impacts

BEHAVIORAL

Study of the long-term side effects of oncological treatments on the anxiety-depressive and cognitive state of patients

Cognitive and anxiety-depressive evaluation of patients who have received oncological treatments, away from the latest treatments to assess their impacts

Trial Locations (1)

69310

Service de Rhumatologie, Hospices Civils de Lyon, Groupement Hospitalier Lyon Sud, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER